articleACS Chemical NeuroscienceMar 19, 2016HYBRID OA

Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery

Pfizer (United States)

PubMed
Indexed incrossrefpubmed

Abstract

Significant progress has been made in prospectively designing molecules using the central nervous system multiparameter optimization (CNS MPO) desirability tool, as evidenced by the analysis reported herein of a second wave of drug candidates that originated after the development and implementation of this tool. This simple-to-use design algorithm has expanded design space for CNS candidates and has further demonstrated the advantages of utilizing a flexible, multiparameter approach in drug discovery rather than individual parameters and hard cutoffs of physicochemical properties. The CNS MPO tool has helped to increase the percentage of compounds nominated for clinical development that exhibit alignment of…

Citation impact

596
total citations
FWCI
34.60
Percentile
100%
References
13
Citations per year

Authors

4

Topics & keywords

Keywords
  • ADME
  • Drug discovery
  • Drug development
  • Prioritization
  • Drug
  • Computer science
  • Chemical space
  • Computational biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding